| Primary |
| Paroxysmal Nocturnal Haemoglobinuria |
67.5% |
| Haemolytic Uraemic Syndrome |
7.0% |
| Hypertension |
4.3% |
| Pain |
2.6% |
| Prophylaxis |
2.3% |
| Premedication |
2.0% |
| Product Used For Unknown Indication |
1.9% |
| Diabetes Mellitus |
1.4% |
| Nausea |
1.4% |
| Supplementation Therapy |
1.3% |
| Hypothyroidism |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Anaemia |
1.0% |
| Anticoagulant Therapy |
0.8% |
| Aplastic Anaemia |
0.8% |
| Insomnia |
0.8% |
| Blood Pressure |
0.8% |
| Prophylaxis Against Transplant Rejection |
0.7% |
| Depression |
0.7% |
| Anxiety |
0.7% |
|
| Headache |
10.3% |
| Haemoglobin Decreased |
8.7% |
| Pyrexia |
8.6% |
| Fatigue |
7.6% |
| Vomiting |
7.1% |
| Death |
6.4% |
| Nasopharyngitis |
6.3% |
| Haemolysis |
5.2% |
| Platelet Count Decreased |
4.7% |
| Nausea |
4.2% |
| Urinary Tract Infection |
4.0% |
| Pneumonia |
3.8% |
| White Blood Cell Count Decreased |
3.7% |
| Back Pain |
3.0% |
| Pain In Extremity |
2.8% |
| Sinusitis |
2.8% |
| Unevaluable Event |
2.7% |
| Transfusion |
2.7% |
| Viral Infection |
2.7% |
| Pain |
2.5% |
|
| Secondary |
| Paroxysmal Nocturnal Haemoglobinuria |
58.7% |
| Hypertension |
6.8% |
| Premedication |
5.2% |
| Prophylaxis |
3.4% |
| Pain |
3.0% |
| Haemolytic Uraemic Syndrome |
2.7% |
| Product Used For Unknown Indication |
2.3% |
| Supplementation Therapy |
2.0% |
| Diabetes Mellitus |
1.9% |
| Vitamin Supplementation |
1.9% |
| Hypothyroidism |
1.7% |
| Nausea |
1.6% |
| Anticoagulant Therapy |
1.6% |
| Anaemia |
1.4% |
| Thrombosis Prophylaxis |
1.3% |
| Routine Health Maintenance |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Contraception |
0.9% |
| Migraine |
0.8% |
| Sleep Disorder |
0.8% |
|
| Vomiting |
13.2% |
| Pyrexia |
10.8% |
| White Blood Cell Count Decreased |
9.3% |
| Headache |
6.5% |
| Urinary Tract Infection |
6.5% |
| Haemoglobin Decreased |
6.4% |
| Haemolysis |
6.1% |
| Nasopharyngitis |
4.7% |
| Platelet Count Decreased |
4.5% |
| Weight Increased |
4.5% |
| Nausea |
4.0% |
| Pain |
3.2% |
| Upper Respiratory Tract Infection |
3.2% |
| Pneumonia |
3.0% |
| Sinusitis |
3.0% |
| Fatigue |
2.6% |
| White Blood Cell Count Increased |
2.4% |
| Vision Blurred |
2.1% |
| Rash |
2.1% |
| Swelling Face |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
18.2% |
| Paroxysmal Nocturnal Haemoglobinuria |
8.3% |
| Haemolytic Uraemic Syndrome |
6.8% |
| Prophylaxis |
6.1% |
| Cytomegalovirus Infection |
3.8% |
| Iron Overload |
3.8% |
| Urinary Tract Infection |
3.0% |
| Immunosuppression |
2.3% |
| Aspergillus Infection |
1.5% |
| Atrial Flutter |
1.5% |
| Gastrointestinal Candidiasis |
1.5% |
| Graft Haemorrhage |
1.5% |
| Myelodysplastic Syndrome |
1.5% |
| Paroxysmal Nocturnal Hemoglobinuria |
1.5% |
| Pulmonary Embolism |
1.5% |
| Renal Transplant |
1.5% |
| Anxiety |
0.8% |
| Blood Pressure |
0.8% |
| Budd-chiari Syndrome |
0.8% |
|
| Transient Ischaemic Attack |
15.4% |
| White Blood Cell Count Increased |
11.5% |
| Myocardial Infarction |
7.7% |
| Urosepsis |
7.7% |
| Agranulocytosis |
3.8% |
| Blood Pressure Diastolic Decreased |
3.8% |
| Dehydration |
3.8% |
| Dysphagia |
3.8% |
| Ear Haemorrhage |
3.8% |
| Heart Valve Replacement |
3.8% |
| Renal Failure Chronic |
3.8% |
| Scrotal Swelling |
3.8% |
| Swelling Face |
3.8% |
| Thrombosis |
3.8% |
| Thrombotic Microangiopathy |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| Vomiting |
3.8% |
| Weight Increased |
3.8% |
|
| Interacting |
| Paroxysmal Nocturnal Haemoglobinuria |
100.0% |
|
| Malaise |
50.0% |
| Paraesthesia |
50.0% |
|
